Skip to main navigation Skip to search Skip to main content

TRPML2 channel modulation by PI(3,5)P₂ and small-molecule agonists controls endosomal vesicle dynamics

  • Zi Qi Gu
  • , Hsuan Ti Wang
  • , Yanfen Li
  • , Einar Krogsaeter
  • , Alice C. Lin
  • , Jackson Lin
  • , Yi Shan Liu
  • , Wei Shuan Lin
  • , William Burton
  • , Mu Lin Liu
  • , Colin Feldmann
  • , Rachel Tang
  • , Ching Wen Po
  • , Pei Shan Hou
  • , Neng Yu Lin
  • , Jing Yi Lin
  • , Tai Ling Chao
  • , Sui Yuan Chang
  • , Zhuo Yang
  • , Marco Keller
  • Charlotte Leser, Stefanie Fenske, Franz Bracher, Christian Wahl-Schott, Antony Galione, Yu Huan Tsai, Christian Grimm, Martin Biel, Cheng Chang Chen*
*Corresponding author for this work
  • Chang Gung University
  • National Yang Ming Chiao Tung University
  • National Taiwan University
  • Ludwig Maximilian University of Munich
  • Gladstone Institutes
  • University of Oxford
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Research output: Contribution to journal › Journal Article › peer-review

4 Scopus citations

Abstract

TRPML2 is an endolysosomal calcium-permeable channel gated by phosphatidylinositol 3,5-bisphosphate (PI(3,5)P₂). However, its subcellular localization and functional contribution to compartment-specific vesicle trafficking remain incompletely defined. In this study, we identify Rab4-positive recycling endosomes as a key site of TRPML2 activity and regulation. We further examined a PI(3,5)P₂-insensitive TRPML2 mutant (R310A), which exhibited reduced channel activity, accumulated perinuclear vesicles, and impaired Rab4 + endosomal motility. To restore channel function, we employed two selective small-molecule TRPML2 agonists, ML2-SA1 and ML2-SA2. Endolysosomal patch-clamp recordings confirmed that both compounds activate wild-type TRPML2 and effectively restore channel activity in the R310A mutant. Functional imaging further demonstrated that ML2-SA2 treatment rescues vesicle redistribution, reduces Golgi accumulation, and promotes peripheral vesicle dynamics. Notably, these effects were observed even in the absence of functional PI(3,5)P₂ gating, indicating that small-molecule agonists can bypass endogenous lipid regulation to restore TRPML2 activity. Our findings identify TRPML2 as a druggable ion channel whose activity is essential for maintaining Rab4-dependent vesicle trafficking. This study establishes a mechanistic link between phosphoinositide sensitivity, TRPML2 activation, and endosomal motility, and highlights a potential therapeutic strategy for correcting trafficking defects caused by impaired lipid signaling in immune cells or other pathophysiological contexts involving endosomal stress.

Original languageEnglish
Article number118350
JournalBiomedicine and Pharmacotherapy
Volume189
DOIs
StatePublished - 08 2025

Bibliographical note

Publisher Copyright:
© 2025 The Authors

Keywords

  • Endosomal trafficking
  • Host defense
  • Phosphoinositides (PIPs)
  • Rab4
  • TRPML

Fingerprint

Dive into the research topics of 'TRPML2 channel modulation by PI(3,5)P₂ and small-molecule agonists controls endosomal vesicle dynamics'. Together they form a unique fingerprint.

Cite this